cRPO growth reaccelerates; eyes on new AI product launch
An Eye on Methane: International Methane Emissions Observatory 2023 Report
–Eyes on the FDA approval of fruquintinib in Nov
How Nations Become Fragile: An AI-Augmented Bird’s-Eye View (with a Case Study of South Sudan)
Eyes on the recovery and risk-reward
Eyeing on the pace of fundamental recovery post sentiment rebound
1H24E preview： eyes on Android recovery and smart tech growth
Positive profit alert for FY22; eyeing for a good FY23E
–Solid 2Q23 earnings quality; Eyes on upmarket
China Technology–Global fabless／IDM 2Q23 wrap： expect continued inventory correction for non-AI players; All eyes on NVDA 3Q23E guidance
公众号
小程序
社群
公众号小程序社群